Valeant seeing early impact on profits from acquisition of Bausch and Lomb - je.st - Valeant seeing early impact on profits from acquisition of Bausch and Lomb

Home › Valeant seeing early impact on profits from acquisition of Bausch and Lomb

Valeant seeing early impact on profits from acquisition of Bausch and Lomb

2014-02-27 23:30:03| Biotech - Topix.net

Valeant Pharmaceuticals International Inc. is reporting net income of $124 million for the fourth quarter of 2013, or 36 cents per diluted share.

Tags: early impact acquisition profits

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

16.11	GLAY REVIEW
16.11	1China Princess
16.11	CB716 5P
16.11	TXT freeze
16.11	/
16.11
16.11	TOMICA D D limited stage
16.11
More »